Dr. Dinella has been recognized for her achievements in the industry; in 1990, she received both the Upjohn Pharmacy Research Award for Excellence in Clinical Research and the Sandoz Pharmacy Award for Superior Academic Achievement & Contribution to Health Care; in 2000, she graduated from the Leadership New Jersey program designed to take proven professional leaders and make them Leaders of State issues within health care, environmental, social services, education, politics, and racism; in 2001, she received the Tribute to Women in Industry (TWIN) Award (2001) in recognition of her significant contributions to her company as a professional woman.
Bonnie Hepburn, M.D.
Dr. Hepburn is a rheumatologist with more than 20 years of experience in drug development and was formerly chair of the FDA's Arthritis Advisory Committee. She currently serves as a Clinical Professor in the Department of Medicine, Division of Rheumatology/Allergy/Immunology, at the University of California San Diego and as a consultant to private and public pharmaceutical and biopharmaceutical companies. She has been directly involved in planning clinical and regulatory strategy for multiple products including new molecular entities, both xenobiotics and biologic agents, across different platforms and multiple therapeutic areas. She has had numerous opportunities to interact directly with the FDA, leading early and late stage development meetings and overseeing NDA submissions that resul
|SOURCE ADVENTRX Pharmaceuticals, Inc.|
Copyright©2010 PR Newswire.
All rights reserved